HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
about
Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobinsEffects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat modelThe use of the Revised Trauma Score as an entry criterion in traumatic hemorrhagic shock studies: data from the DCLHb clinical trials.Dose-Dependent Hemodynamic, Biochemical, and Tissue Oxygen Effects of OC99 following Severe Oxygen Debt Produced by Hemorrhagic Shock in Dogs.Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide.Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states.Simulation of NO and O2 transport facilitated by polymerized hemoglobin solutions in an arteriole that takes into account wall shear stress-induced NO productionExamining and mitigating acellular hemoglobin vasoactivity.Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients.The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
P2860
Q33721951-CCEC74BE-27D0-4110-9552-011596640691Q34302155-6F796492-7C9A-4D27-9ACC-EC9649E3FD00Q34354806-B747275A-9C2D-4239-B404-998DD31E5E65Q34487433-4D693EDF-8B9A-4946-9C1F-CB8834794693Q34501963-84E7354C-C290-4454-A8B1-F25FD34BFC69Q34715341-E6076FEF-5101-4310-965D-ED41A1ABAFF1Q35783934-734CB974-6087-433C-A8B3-163E0357F230Q36801603-C117BDE5-EA22-43E6-8EA3-670E52BBD4E8Q36990411-493431A6-F88B-4751-8970-03E5DA90AD03Q37729403-D00958A5-7C89-4902-9882-AC1510AD3395Q46228436-D924B12D-B04F-4BC6-B2CB-3F3D5A3BD240Q50133464-04B392BF-AC74-4B51-AB40-CEF338C2F035
P2860
HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@ast
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@en
type
label
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@ast
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@en
prefLabel
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@ast
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@en
P2093
P1433
P1476
HBOC-201 vasoactivity in a pha ...... risk for acute trauma trials.
@en
P2093
Arkadiy Pitman
Daniel Freilich
Gerson Greenburg
L Bruce Pearce
Lolita Bebris
Mara Berzins
Richard McCarron
Steven Ahlers
P304
P356
10.1097/TA.0B013E3181820D5C
P407
P577
2009-02-01T00:00:00Z